Dentium

145720 · KOSPI · Health Care · SMALL CAP

Provisional Q1 2026 results.

Dentium filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$47.8M (−7.1% year on year), operating profit of US$10.6M (+65.4% year on year) and net income of US$11.4M (+34.5% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-05-12· RCEPT 20260512800558

US$47.8MRevenue
−7.1%Revenue vs a year earlier
US$10.6MOperating profit

Converted at 1 USD ≈ ₩1,492.99 (filing-date rate, 2026-05-12 close)

What happened

Dentium filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$47.8M (−7.1% year on year), operating profit of US$10.6M (+65.4% year on year) and net income of US$11.4M (+34.5% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$47.8M
Revenue vs a year earlier−7.1%
Operating profitUS$10.6M
Net incomeUS$11.4M
PeriodQ1 2026 (consolidated)
Filed2026-05-12, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260512800558 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-12 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.